Skip to content

Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging

Response Prediction After Gamma Knife Surgery (GKS) in Patients With Vestibular Schwannoma Using Dynamic Contrast-Enhanced (DCE) MR Imaging

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03097822
Enrollment
90
Registered
2017-03-31
Start date
2017-01-31
Completion date
Unknown
Last updated
2017-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Schwannoma

Brief summary

Response Prediction after Gamma Knife Surgery (GKS) in Patients with Vestibular Schwannoma using Dynamic Contrast-Enhanced (DCE) MR Imaging

Detailed description

The purpose of this study was to evaluate the response of Gamma Knife Surgery to Ktrans, Ve, and Vp, which are indicators of permeability map obtained from dynamic contrast enhanced (DCE) MRI in patients with vestibular schwannoma .

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with vestibular schwannoma, who underwent gamma knife surgery and pre-op dynamic contrast enhanced (DCE) MRI * Patients with vestibular schwannoma, who received consent

Exclusion criteria

* In addition to the vestibular schwannoma, if the brain has other underlying or systemic disease * During the observation period, other treatments were performed other than gamma knife surgery * If patients have a contraindication to MRI (eg, pacemaker, cochlear implants, hemodynamically unstable) * Concomitant use of gadolinium MRI contrast agents (eg, renal insufficiency \[glomerular filtration rate \<30 ML / min\]), or if there was a side effect when using a contrast medium. * Adults with impaired ability to cope * If the images and medical records required for this study are not available or are not appropriate

Design outcomes

Primary

MeasureTime frame
Tumor size change before and after surgerypre-op, Immediately after surgery

Secondary

MeasureTime frame
In patients who underwent gamma knife surgery, the magnitude of tumor size change before and after surgerythrough study completion, an average of 1 year

Contacts

Primary ContactSeungHong Choi, MD,PhD
verocay@snuh.org

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026